Search Results - "HULAND, H."

Depression, anxiety, post-traumatic stress disorder and health-related quality of life and its association with social support in ambulatory prostate cancer patients by MEHNERT, A., LEHMANN, C., GRAEFEN, M., HULAND, H., KOCH, U.

“…MEHNERT A., LEHMANN C., GRAEFEN M., HULAND H. & KOCH U. (2010) European Journal of Cancer Care19, 736–745
Depression, anxiety, post‐traumatic stress disorder…”
Get full text

Defining a Standard Set of Patient-Centered Outcomes for Men With Localized Prostate Cancer by Martin, N.E, Massey, L, Stowell, C, Huland, H

Get full text

Prognostic relevance of Bcl-2 overexpression in surgically treated prostate cancer is not caused by increased copy number or translocation of the gene by Fleischmann, A., Huland, H., Mirlacher, M., Wilczak, W., Simon, R., Erbersdobler, A., Sauter, G., Schlomm, T.

“…BACKGROUND Overexpression of anti‐apoptotic Bcl‐2 plays a role in prostate cancer progression, particularly in transformation to androgen‐independent disease…”
Get full text

Comparison of early salvage and adjuvant radiotherapy for non-organ-confined prostate cancer after radical prostatectomy by Preisser, F., Pompe, R.S., Chun, F.K.H., Graefen, M., Huland, H., Tilki, D.

Get full text

Effect of tumor characteristics on functional outcomes after radical prostatectomy by Stolzenbach, L.F., Pompe, R.S., Preisser, F., Knipper, S., Graefen, M., Huland, H., Tilki, D.

Get full text

Impact of positive surgical margin length and Gleason grade at the margin on oncologic outcomes in patients with non-organ-confined prostate cancer by Preisser, F., Heinze, A., Pompe, R.S., Chun, F.K.H., Graefen, M., Huland, H., Tilki, D.

Get full text

Risk of metastasis in patients with delayed biochemical recurrence 10 years after radical prostatectomy by Preisser, F., Pompe, R.S., Chun, F.K.H., Graefen, M., Huland, H., Tilki, D.

Get full text

Adherence of the indication to European Association of Urology guideline recommended pelvic lymph node dissection at a high-volume center: Differences between open and robot-assisted radical prostatectomy by Schiffmann, J, Haese, A, Leyh-Bannurah, Sami-Ramzi, Salomon, G, Steuber, T, Schlomm, T, Boehm, K, Beyer, B, Larcher, A, Michl, U, Heinzer, H, Huland, H, Graefen, M, Karakiewicz, P.I

“…Abstract Purpose Contemporary adherence of the indication to European Association of Urology (EAU) guideline recommendation for pelvic lymph node dissection…”
Get full text

Urodynamic evaluation of changes in urinary control after radical retropubic prostatectomy by Hammerer, P, Huland, H

“…Urodynamic evaluations were done in patients before and after radical prostatectomy to obtain more information about the factors that affect continence…”
Get more information

Impact of adjuvant radiotherapy in patients with high burden lymph node metastases after radical prostatectomy by Pompe, R.S., Preisser, F., Gild, P., Mandel, P., Steuber, T., Salomon, G., Graefen, M., Huland, H., Fisch, M., Tilki, D.

Get full text

Association of very low PSA with increased metastases and death in patients with biopsy Gleason score 8-10 prostate cancer by Pompe, R.S., Preisser, F., Leyh-Bannurah, S., Gild, P., Salomon, G., Graefen, M., Fisch, M., Huland, H., Tilki, D.

Get full text

[F18 ]-fluoroethylcholine combined in-line PET-CT scan for detection of lymph-node metastasis in high risk prostate cancer patients prior to radical prostatectomy: Preliminary results from a prospective histology-based study by Steuber, T, Schlomm, T, Heinzer, H, Zacharias, M, Ahyai, S, Chun, K.F, Haese, A, Klutmann, S, Köllermann, J, Sauter, G, Mester, J, Mikecz, P, Fisch, M, Huland, H, Graefen, M, Salomon, G

“…Abstract Purpose To evaluate the diagnostic potential of PET/CT using ([F18 ]fluorethylcholine (FEC) for lymph node (LN) staging in high risk prostate cancer…”
Get full text

EAU BCR risk classification as decision tool for salvage radiatiotherapy by Pompe, R.S., Wiegel, T., Bartkowiak, D., Preisser, F., Leyh-Bannurah, S., Gild, P., Salomon, G., Graefen, M., Siegmann, A., Böhmer, D., Budach, V., Fisch, M., Huland, H., Tilki, D.

Get full text

Early urinary continence a reliable marker for further functional outcomes by Pompe, R.S., Preisser, F., Gild, P., Mandel, P., Leyh-Bannurah, S.R., Salomon, G., Graefen, M., Huland, H., Fisch, M., Tilki, D.

Get full text

Salvage radiotherapy versus observation for biochemical recurrence following radical prostatectomy for prostate cancer: A matched pair analysis by Preisser, F., Wiegel, T., Bartkowiak, D., Pompe, R.S., Chun, F.K.H., Graefen, M., Siegmann, A., Böhmer, D., Budach, V., Huland, H., Tilki, D.

Get full text

Influence of low-molecular-weight heparin dosage on red blood cell transfusion, lymphocele rate and drainage duration after open radical prostatectomy by Schmitges, J, Trinh, Q.-D, Jonas, L, Budäus, L, Larbig, R, Schlomm, T, Karakiewicz, P.I, Heinzer, H, Huland, H, Graefen, M, Steuber, T

“…Abstract Background To assess the rates of red blood cell (RBC) transfusions, pelvic lymphoceles, and prolonged drainage duration in patients after radical…”
Get full text

CEA-related cell adhesion molecule-1 is involved in angiogenic switch in prostate cancer by TILKI, D, IRMAK, S, STIEF, C. G, KILIC, E, HULAND, H, ERGUN, S, OLIVEIRA-FERRER, L, HAUSCHILD, J, MIETHE, K, ATAKAYA, H, HAMMERER, P, FRIEDRICH, M. G, SCHUCH, G, GALALAE, R

“…We demonstrate here that epithelial carcinoembryonic antigen (CEA)-related cell adhesion molecule-1 (CEACAM1) downregulation in prostate intraepithelial…”
Get full text

Radical prostatectomy: options and issues by Huland, H

“…Radical prostatectomy is an effective treatment for patients with clinically localized prostate cancer and is associated with a very low level of mortality…”
Get more information

High Nr-CAM expression is associated with favorable phenotype and late PSA recurrence in prostate cancer treated by prostatectomy by Tsourlakis, M C, Walter, E, Quaas, A, Graefen, M, Huland, H, Simon, R, Sauter, G, Steurer, S, Schlomm, T, Minner, S

“…Background: Neuron-glia-related cell-adhesion molecule (Nr-CAM) is another potential membrane-bound target molecule for specific prostate cancer therapy. The…”
Get full text

Partin Tables cannot accurately predict the pathological stage at radical prostatectomy by Bhojani, N, Ahyai, S, Graefen, M, Capitanio, U, Suardi, N, Shariat, S.F, Jeldres, C, Erbersdobler, A, Schlomm, T, Haese, A, Steuber, T, Heinzer, H, Montorsi, F, Huland, H, Karakiewicz, P.I

“…Abstract Purpose The Partin Tables represent the most commonly used staging tool for radical prostatectomy (RP) candidates. The Partin Tables' predictions are…”
Get full text